Genpact Extends Partnership With Ferring To Boost Finance And Procurement Operations

Genpact, a global firm that delivers innovative services, has partnered with Ferring Pharmaceuticals, a biopharmaceutical company in over 50 countries. The renewed multi-year agreement will continue transforming Ferring’s finance, accounting, and procurement operations through advanced technologies like AI. 

Sanjiv Tandon, Global Head of Life Sciences and Healthcare, Genpact, said in a statement, "To drive growth in a complex and competitive environment, pharmaceutical companies need modern, scalable and efficient solutions. Our ongoing partnership with Ferring Pharmaceuticals leverages our industry expertise and a shared vision to harness advanced technologies, setting a new standard for innovation and enabling Ferring to meet evolving demands with speed and accuracy."

With this new agreement, Genpact will streamline workflows, improve resource management, and speed up the accuracy of financial transactions. The collaboration with tech companies like Xelix and Blackline will automate essential processes such as invoice management and procurement. The partnership will also boost data analytics capabilities, providing Ferring with real-time financial insights. These upgrades are designed to provide financial support by reducing operational costs and helping Ferring meet the evolving needs of customers and patients.

Dominic Moorhead, Chief Financial Officer of Ferring Pharmaceuticals, stated, "Our partnership with Genpact spans over 40 digital transformation projects, with a strong focus on AI applications. By standardizing processes and leveraging advanced technologies, like AI, we're enhancing accuracy, real-time insights, and overall efficiency to support our purpose of building families and helping people live better lives."

This extended collaboration highlights Ferring Pharmaceuticals’ commitment to innovation, empowering them to continue delivering novel treatments that make a difference in people's lives worldwide.